Skip to main content
All lobbying clients

NOVOZYMES NORTH AMERICA INC.

Lobbying client · North Carolina · filed 2025 to 2026

Biosolutions company.

$200,000 Reported spend
5 Filings counted
1 Firms hired
2 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (67958), not by name.

 Firms hired 1
 Bills named in these filings 2
  • HR 4794
    Dietary Supplements Access Act
    1 filing
  • S 3172
    A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement prod…
    1 filing
 Reported by year 2 years
  • 2026 $100,000 2 filings
  • 2025 $100,000 3 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 4
  • SENATE 4
  • White House Office 1
 Foreign entities disclosed 1
  • NOVOZYMES A/S Denmark named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem